vs

Side-by-side financial comparison of EDGEWELL PERSONAL CARE Co (EPC) and PITNEY BOWES INC (PBI). Click either name above to swap in a different company.

PITNEY BOWES INC is the larger business by last-quarter revenue ($477.6M vs $422.8M, roughly 1.1× EDGEWELL PERSONAL CARE Co). PITNEY BOWES INC runs the higher net margin — 5.7% vs -15.5%, a 21.3% gap on every dollar of revenue. On growth, PITNEY BOWES INC posted the faster year-over-year revenue change (-7.5% vs -11.6%). PITNEY BOWES INC produced more free cash flow last quarter ($201.4M vs $-137.5M). Over the past eight quarters, PITNEY BOWES INC's revenue compounded faster (-4.3% CAGR vs -16.0%).

The Edgewell Personal Care Company is an American multinational consumer products company headquartered in Shelton, Connecticut. It was formed in 2015 following the corporate spin-off from Energizer Holdings, Inc..

Pitney Bowes is a global technology and logistics company that provides e-commerce shipping, mailing processing, order fulfillment, and customer information management solutions. It serves small, medium, and large enterprise clients across retail, financial services, healthcare, and government sectors worldwide, helping businesses optimize logistics and customer engagement workflows.

EPC vs PBI — Head-to-Head

Bigger by revenue
PBI
PBI
1.1× larger
PBI
$477.6M
$422.8M
EPC
Growing faster (revenue YoY)
PBI
PBI
+4.2% gap
PBI
-7.5%
-11.6%
EPC
Higher net margin
PBI
PBI
21.3% more per $
PBI
5.7%
-15.5%
EPC
More free cash flow
PBI
PBI
$338.9M more FCF
PBI
$201.4M
$-137.5M
EPC
Faster 2-yr revenue CAGR
PBI
PBI
Annualised
PBI
-4.3%
-16.0%
EPC

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
EPC
EPC
PBI
PBI
Revenue
$422.8M
$477.6M
Net Profit
$-65.7M
$27.3M
Gross Margin
38.1%
Operating Margin
-4.5%
8.0%
Net Margin
-15.5%
5.7%
Revenue YoY
-11.6%
-7.5%
Net Profit YoY
-3028.6%
173.1%
EPS (diluted)
$-1.41
$0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EPC
EPC
PBI
PBI
Q4 25
$422.8M
$477.6M
Q3 25
$600.5M
$459.7M
Q2 25
$627.2M
$461.9M
Q1 25
$580.7M
$493.4M
Q4 24
$415.1M
$516.1M
Q3 24
$517.6M
$499.5M
Q2 24
$647.8M
$489.7M
Q1 24
$599.4M
$521.3M
Net Profit
EPC
EPC
PBI
PBI
Q4 25
$-65.7M
$27.3M
Q3 25
$-30.6M
$52.0M
Q2 25
$29.1M
$30.0M
Q1 25
$29.0M
$35.4M
Q4 24
$-2.1M
$-37.4M
Q3 24
$8.8M
$-138.5M
Q2 24
$49.0M
$-24.9M
Q1 24
$36.0M
$-2.9M
Gross Margin
EPC
EPC
PBI
PBI
Q4 25
38.1%
Q3 25
37.9%
Q2 25
42.8%
Q1 25
44.1%
Q4 24
41.6%
53.8%
Q3 24
41.1%
52.4%
Q2 24
44.3%
51.1%
Q1 24
43.1%
52.3%
Operating Margin
EPC
EPC
PBI
PBI
Q4 25
-4.5%
8.0%
Q3 25
-4.2%
14.8%
Q2 25
8.6%
8.5%
Q1 25
10.1%
9.5%
Q4 24
2.2%
-9.3%
Q3 24
3.9%
-8.8%
Q2 24
12.8%
-1.6%
Q1 24
11.7%
9.1%
Net Margin
EPC
EPC
PBI
PBI
Q4 25
-15.5%
5.7%
Q3 25
-5.1%
11.3%
Q2 25
4.6%
6.5%
Q1 25
5.0%
7.2%
Q4 24
-0.5%
-7.2%
Q3 24
1.7%
-27.7%
Q2 24
7.6%
-5.1%
Q1 24
6.0%
-0.6%
EPS (diluted)
EPC
EPC
PBI
PBI
Q4 25
$-1.41
$0.18
Q3 25
$-0.65
$0.30
Q2 25
$0.62
$0.17
Q1 25
$0.60
$0.19
Q4 24
$-0.04
$-0.21
Q3 24
$0.18
$-0.75
Q2 24
$0.98
$-0.14
Q1 24
$0.72
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EPC
EPC
PBI
PBI
Cash + ST InvestmentsLiquidity on hand
$297.1M
Total DebtLower is stronger
$1.5B
$2.0B
Stockholders' EquityBook value
$1.5B
$-802.4M
Total Assets
$3.8B
$3.2B
Debt / EquityLower = less leverage
1.03×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EPC
EPC
PBI
PBI
Q4 25
$297.1M
Q3 25
$336.0M
Q2 25
$300.8M
Q1 25
$340.0M
Q4 24
$486.1M
Q3 24
$209.1M
$575.5M
Q2 24
$612.0M
Q1 24
$538.0M
Total Debt
EPC
EPC
PBI
PBI
Q4 25
$1.5B
$2.0B
Q3 25
$1.4B
$2.1B
Q2 25
$1.4B
$1.9B
Q1 25
$1.4B
$1.9B
Q4 24
$1.4B
$1.9B
Q3 24
$1.3B
$2.1B
Q2 24
$1.3B
$2.1B
Q1 24
$1.4B
$2.1B
Stockholders' Equity
EPC
EPC
PBI
PBI
Q4 25
$1.5B
$-802.4M
Q3 25
$1.6B
$-661.5M
Q2 25
$1.6B
$-536.8M
Q1 25
$1.5B
$-535.9M
Q4 24
$1.5B
$-578.4M
Q3 24
$1.6B
$-518.9M
Q2 24
$1.6B
$-427.9M
Q1 24
$1.6B
$-392.4M
Total Assets
EPC
EPC
PBI
PBI
Q4 25
$3.8B
$3.2B
Q3 25
$3.8B
$3.3B
Q2 25
$3.8B
$3.2B
Q1 25
$3.8B
$3.3B
Q4 24
$3.7B
$3.4B
Q3 24
$3.7B
$3.6B
Q2 24
$3.7B
$4.1B
Q1 24
$3.8B
$4.1B
Debt / Equity
EPC
EPC
PBI
PBI
Q4 25
1.03×
Q3 25
0.89×
Q2 25
0.88×
Q1 25
0.95×
Q4 24
0.97×
Q3 24
0.81×
Q2 24
0.82×
Q1 24
0.88×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EPC
EPC
PBI
PBI
Operating Cash FlowLast quarter
$-125.9M
$221.7M
Free Cash FlowOCF − Capex
$-137.5M
$201.4M
FCF MarginFCF / Revenue
-32.5%
42.2%
Capex IntensityCapex / Revenue
2.7%
4.2%
Cash ConversionOCF / Net Profit
8.11×
TTM Free Cash FlowTrailing 4 quarters
$36.3M
$317.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EPC
EPC
PBI
PBI
Q4 25
$-125.9M
$221.7M
Q3 25
$74.1M
$66.8M
Q2 25
$114.8M
$111.4M
Q1 25
$45.1M
$-16.7M
Q4 24
$-115.6M
$134.5M
Q3 24
$-388.3M
$14.7M
Q2 24
$101.2M
$92.6M
Q1 24
$129.0M
$-12.6M
Free Cash Flow
EPC
EPC
PBI
PBI
Q4 25
$-137.5M
$201.4M
Q3 25
$46.5M
$51.1M
Q2 25
$99.3M
$98.0M
Q1 25
$28.0M
$-33.6M
Q4 24
$-132.4M
$112.3M
Q3 24
$-414.2M
$-4.7M
Q2 24
$88.6M
$76.1M
Q1 24
$117.5M
$-26.9M
FCF Margin
EPC
EPC
PBI
PBI
Q4 25
-32.5%
42.2%
Q3 25
7.7%
11.1%
Q2 25
15.8%
21.2%
Q1 25
4.8%
-6.8%
Q4 24
-31.9%
21.8%
Q3 24
-80.0%
-0.9%
Q2 24
13.7%
15.5%
Q1 24
19.6%
-5.2%
Capex Intensity
EPC
EPC
PBI
PBI
Q4 25
2.7%
4.2%
Q3 25
4.6%
3.4%
Q2 25
2.5%
2.9%
Q1 25
2.9%
3.4%
Q4 24
4.0%
4.3%
Q3 24
5.0%
3.9%
Q2 24
1.9%
3.4%
Q1 24
1.9%
2.7%
Cash Conversion
EPC
EPC
PBI
PBI
Q4 25
8.11×
Q3 25
1.29×
Q2 25
3.95×
3.72×
Q1 25
1.56×
-0.47×
Q4 24
Q3 24
-44.13×
Q2 24
2.07×
Q1 24
3.58×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EPC
EPC

Other$242.0M57%
Sunand Skin Care Segment$131.5M31%
Shavinggelsandcreams$32.3M8%
Wipes And Other Skin Care Products$17.0M4%

PBI
PBI

Sales And Services$218.4M46%
Presort Services$159.7M33%
Financing And Other$79.0M17%
Other$20.5M4%

Related Comparisons